NCT07678307
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Explore clinical trials studying Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.
297 public trials
56 recruiting studies
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trial results
Not yet recruiting
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment
NCT07636564
- Conditions
- Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, +24 more
- Locations
-
Not specified
Not yet recruiting
Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission
NCT07577531
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL
NCT07476027
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
Not specified
Not yet recruiting
HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
NCT07175415
- Conditions
- Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +19 more
- Locations
-
Not specified
Not yet recruiting
The Safety and Efficacy of VGO-Cs01p in Patients With CD7-positive Relapsed/Refractory Acute T-lymphoblastic Leukemia
NCT06849401
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
Not specified
Not yet recruiting
Allo-HSCT vs ASCT in Adult T-LBL
NCT06741813
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
Not specified
Enrolling by invitation
A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies
NCT07784309
- Conditions
- Acute Myeloid Leukemia (AML), Acute T Cell Lymphoblastic Leukemia, Hematologic Diseases, +18 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
Enrolling by invitation
A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
NCT05509855
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- City of Hope Duarte, California, United States
- Childrens Hospital LA Los Angeles, California, United States
- Washington University St Louis, Missouri, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Active, not recruiting
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting
NCT04128501
- Conditions
- Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States